According to a report by Bovnews, UBS, the Swiss multinational investment bank, has raised its target price for RELX Technology (RLX Technology Inc) to a "buy" rating. This rating was issued on August 8, 2023.
On November 24th, the stock price of RELX Technology rose by 1.36% to close at $2.23, higher than the previous day's closing price.
During the entire trading session, the stock price fluctuated between $2.01 and $2.26, with a trading volume of 11,899,145 shares, significantly higher compared to the three-month average trading volume of 5.61 million shares.
The company's stock prices have witnessed fluctuations of 9.85% in the last five trading sessions and 41.14% in the last thirty trading sessions, indicating a significant change compared to the beginning of the year. Despite a 9.85% increase in stock prices over the past six months, its value has surged by 55.94% in the last three months.
The profit margins for RLX stock compared to its 20-day, 50-day, and 200-day simple moving average prices are 22.33%, 34.76%, and 14.75% respectively.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
![[Breaking] Juul’s Device and 4 Pod Products Officially Authorized by FDA, Reenters the U.S. Regulated Market](https://static.2firsts.com/uploads/20241113/34ffc17feb2b6076367c9e5f413641f2.jpg?x-oss-process=style/origin)
